Posterior Scleritis in Psoriatic Arthritis

Altan-Yaycıoğlu, Rana; Akova, Yonca A.; Kart, Hamide; Çetinkaya, Altuğ; Yılmaz, Gürsel; Aydin, Pınar

doi:10.1097/00006982-200310000-00022

Cited by 20 publications

(11 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, there are no clear guidelines regarding use of NSAID in patients with IBD as it is unclear whether NSAID may exacerbate IBD symptoms 75,76 . The ophthalmic manifestations of PsA include uveitis, keratitis, blepharitis, conjunctivitis, episcleritis, and scleritis 19,20,21 . The prevalence and spectrum of autoimmune ophthalmic disease in PsA is significant and the associated potential morbidity is high 19,77 .…”

Section: Cardiovascular Diseasementioning

confidence: 99%

See 1 more Smart Citation

Comprehensive Treatment of Psoriatic Arthritis: Managing Comorbidities and Extraarticular Manifestations

et al. 2014

View full text Add to dashboard Cite

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

show abstract

Section: Cardiovascular Diseasementioning

confidence: 99%

“…Diabetes. Autoimmune ophthalmic disease, including uveitis, keratitis, blepharitis, conjunctivitis, episcleritis, and scleritis, have been observed 19,20,21 . Inflammatory bowel diseases (IBD).…”

mentioning

confidence: 99%

Comprehensive Treatment of Psoriatic Arthritis: Managing Comorbidities and Extraarticular Manifestations

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Although systemic conditions are associated with 29% of cases of posterior scleritis, this was the first report of an association of psoriatic arthritis indicating a possible, albeit infrequent, association. [68][69][70] In a study of 114 patients treated for scleritis from two tertiary eye care centers in Turkey, one patient was given the diagnosis of psoriatic arthritis during the workup. 71 The link among psoriasis, uveitis, and HLA-B27 is not fully understood.…”

Section: Uveamentioning

confidence: 99%

Ocular psoriasis

Rehal

Modjtahedi

Morse

et al. 2011

Journal of the American Academy of Dermatology

103

View full text Add to dashboard Cite

show abstract

“…However scleritis and peripheral ulcerative keratitis can present before or after the onset ofRA or as an isolated condition [12]. Posterior scleritis in psoriatic arthritis with severe visual loss has been reported [13]. Progression of scleritis to the other eye can occur within five years.…”

Section: Discussionmentioning

confidence: 99%

Clinical features, visual outcome and association with systemic disease in patients with episleritis and scleritis. A study of 50 eyes

2016

View full text Add to dashboard Cite

Introduction: Episcleritis and scleritis are inflammatory disorders which can have an acute presentation and are frequently encountered by primary care practitioners.Episcleritis is a benign, self-limited disease that resolves within 2 to 3 weeks. Scleritis is painful, causing visual loss due to uveitis, glaucoma, cataract, and retinal detachment. Both are associated with underlying systemic diseases.We aim to report clinical features, visual outcome and association with systemic disease in patients with visual symptoms. Methods: This is a prospective cohort study conducted on 50 patients over 1 year in a tertiary eye care hospital Complete ophthalmic evaluation was performed. Patients were followed up for one year to look for response to treatment and development of complications. Results: In our study, the incidence of episcleritis was more frequent than scleritis. The age group affected was 34 to 52 years and more in women. Most of our patients with episcleritis showed resolution within 3 weeks. Scleritis was associated with decreased vision and more complications. In both forms of inflammation rheumatoid arthritis, systemic lupus erythematosus and psoriasis were the most common etiology. Conclusion: In rheumatoid arthritis, systemic lupus erythematosus and psoriasis patients, episcleritis and scleritis can be the initial clinical presentation. Clinical features are more severe in scleritis and can be diagnosedwith B scan ultrasound. Visual loss in both can be prevented by early treatment. We found the association with rheumatoid arthritis and SLEto be high in our population. Infections were not as common as autoimmune diseases in the population studied.

show abstract

Posterior Scleritis in Psoriatic Arthritis

Cited by 20 publications

References 5 publications

Comprehensive Treatment of Psoriatic Arthritis: Managing Comorbidities and Extraarticular Manifestations

Comprehensive Treatment of Psoriatic Arthritis: Managing Comorbidities and Extraarticular Manifestations

Ocular psoriasis

Clinical features, visual outcome and association with systemic disease in patients with episleritis and scleritis. A study of 50 eyes

Contact Info

Product

Resources

About